Richtlijn 'Herhaalde miskraam' (eerste herziening) van de Nederlandse Vereniging voor Obstetrie en Gynaecologie

M. Goddijn, E. Van Den Boogaard, E. A.P. Steegers, J. J.H.M. Erwich, N. S. Macklon, J. A. Land, W. M. Ankum

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

    Abstrakt

    - In 2007, the Dutch Society for Obstetrics and Gynaecology issued a revised version of the 1999 guideline on recurrent miscarriage. - The new guideline was developed according to the principles of evidence-based guideline development and includes levels of evidence. - The guideline contains recommendations for effective diagnosis and treatment and explicitly mentions certain diagnostic tests and treatments that should be avoided. - After a thorough investigation of a couples' history, the type of diagnostic tests that should be offered to the couple can be determined. Patients with a low risk of having cytogenetic abnormalities or thrombophilia may be excluded from parental karyotyping and thrombophilia screening, respectively. - Women with confirmed antiphospholipid antibody syndrome should be offered anticoagulation treatment before and during subsequent pregnancies. - Effective therapy for unexplained recurrent miscarriage is lacking. However, the probability of a successful future pregnancy is high. This probability can be estimated based on the number of previous miscarriages and maternal age.

    Bidragets oversatte titelThe guideline 'Recurrent miscarriage' (first revision) of the Dutch Society for Obstetrics and Gynaecology
    OriginalsprogNederlandsk
    Sider (fra-til)1665-1670
    Antal sider6
    TidsskriftNederlands Tijdschrift voor Geneeskunde
    Vol/bind152
    Udgave nummer30
    StatusUdgivet - 26 jul. 2008

    Fingeraftryk

    Udforsk hvilke forskningsemner 'Richtlijn 'Herhaalde miskraam' (eerste herziening) van de Nederlandse Vereniging voor Obstetrie en Gynaecologie' indeholder.

    Citationsformater